Marriage Counselors in Hiawatha, KS Accepting Medicare

4 Marriage Counselors found. Showing 1 - 4

Karen L. Baker, LCMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113    Fax: 785-742-3085

Emily Nicole Hoffman, LCMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113    Fax: 785-742-3085

Mrs. Emily Ziegler, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 909 S 2nd St, Hiawatha, KS 66434 Phone: 785-742-7113    Fax: 785-742-3085

Tobin James Kriwiel Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 N 6th St, Hiawatha, KS 66434 Phone: 785-740-4647

News Archive

Discriminating remembrance may be marker for early stages of memory loss in older adults

People who selectively recalled positive information over neutral and negative information performed worse on memory tests conducted by University of California, Irvine neurobiologists, who said the results suggest that this discriminating remembrance may be a marker for early stages of memory loss in the elderly.

Researchers show how hematopoietic stem cells detect and react to infections

Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide - that is, without signals from growth factors.

New integrated gene logic-chips could have great value in medical care

Gene expression is a fundamental of life, where each cell switches on and off specific genes. Thus, an autonomous device that could control the on-off switching would have great value in medical care.

Researchers discover new vaccine targets to combat malaria

Researchers have discovered new vaccine targets that could help in the battle against malaria. Taking a new, large-scale approach to this search, researchers tested a library of proteins from the Plasmodium falciparum parasite with antibodies produced by the immune systems of a group of infected children.

Genesis Biopharma terminates previously announced proposed public offering

Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, announced today that it is terminating its previously announced proposed public offering pursuant to a preliminary prospectus supplement and an effective shelf registration statement on file with the Securities and Exchange Commission due to market conditions.

Read more Medical News

› Verified 9 days ago